Cypa
干扰素
生物
亲环素A
冠状病毒
病毒学
计算生物学
重新调整用途
病毒
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
药物重新定位
细胞生物学
疾病
人类免疫缺陷病毒(HIV)
传染病(医学专业)
医学
药品
生态学
分子生物学
病理
药理学
作者
Naveen Vankadari,Debnath Ghosal
标识
DOI:10.1021/acs.jpclett.3c02959
摘要
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronavirus and the perpetual rise of new variants warrant investigation of the molecular and structural details of the infection process and modulation of the host defense by viral proteins. This Letter reports the combined experimental and computational approaches to provide key insights into the structural and functional basis of Nsp1's association with different cyclophilins and FKBPs in regulating COVID-19 infection. We demonstrated the real-time stability and functional dynamics of the Nsp1-CypA/FKBP1A complex and investigated the repurposing of potential inhibitors that could block these interactions. Overall, we provided insights into the inhibitory role Nsp1 in downstream interferon production, a key aspect for host defense that prevents the SARS-CoV-2 or related family of corona virus infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI